Calcipotriol. A new topical antipsoriatic

Area of Science:

• Dermatology
• Pharmacology
• Biochemistry

Background:

• Calcipotriol is a synthetic vitamin D analogue with in vitro effects on cell differentiation, proliferation, and lymphocyte activity.
• Its cellular actions resemble 1,25-(OH)2-D3, but with significantly reduced systemic effects on calcium and bone metabolism.
• This unique profile makes calcipotriol a candidate for topical psoriasis treatment.

Purpose of the Study:

• To evaluate the efficacy and safety of calcipotriol ointment for the topical treatment of psoriasis vulgaris.
• To determine appropriate dosage and administration guidelines for calcipotriol ointment.
• To assess the impact of calcipotriol treatment on calcium and bone metabolism.

Main Methods:

• Clinical studies involving over 3000 patients were conducted to assess calcipotriol ointment efficacy and safety.
• Standardized treatment protocols involved twice-daily application of calcipotriol ointment (50 micrograms/g) up to 100 g/week.
• Systemic effects on calcium and bone metabolism were monitored throughout the studies.

Main Results:

• Calcipotriol ointment (50 micrograms/g) demonstrated significant efficacy and safety for both short- and long-term treatment of psoriasis vulgaris.
• Adherence to recommended dosage (up to 100 g/week) ensured no adverse effects on calcium or bone metabolism.
• The treatment is indicated for plaque-type psoriasis vulgaris.

Conclusions:

• Calcipotriol ointment is a well-established, effective, and safe first-line topical therapy for plaque-type psoriasis vulgaris.
• Topical calcipotriol offers localized therapeutic effects with minimal systemic impact on calcium homeostasis.
• The drug has received regulatory approval in multiple countries, supporting its clinical use.